Cash on Hand for Insmed (INSM)
According to Insmed's latest reported financial statements, the company's latest reported cash and short-term investments is $1.43B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
INSM
Currently viewingCash on HandSwitch metric
Latest period
$1.43B
YoY change
-0.3%
5Y CAGR
+21.8%
Peak year (2024)
$1.43B
Latest annual
$1.43B
Cash on Hand history chart for Insmed (INSM) from 1999 to 2025
Cash on Hand history table for Insmed (INSM) from 1999 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $1.43B | -0.3% | ||
| 2024 | $1.43B | +83.7% | ||
| 2023 | $780.45M | -32.0% | ||
| 2022 | $1.15B | +60.2% | ||
| 2021 | $716.78M | +34.5% | ||
| 2020 | $532.76M | +9.3% | ||
| 2019 | $487.43M | -1.5% | ||
| 2018 | $495.07M | +29.9% | ||
| 2017 | $381.17M | +134.4% | ||
| 2016 | $162.59M | -42.5% | ||
| 2015 | $282.88M | +77.7% | ||
| 2014 | $159.23M | +39.8% | ||
| 2013 | $113.89M | +22.6% | ||
| 2012 | $92.94M | +21.8% | ||
| 2011 | $76.27M | -29.4% | ||
| 2010 | $108.05M | -11.6% | ||
| 2009 | $122.18M | +4997.2% | ||
| 2008 | $2.40M | -85.5% | ||
| 2007 | $16.48M | -31.7% | ||
| 2006 | $24.11M | +28.0% | ||
| 2005 | $18.84M | +104.2% | ||
| 2004 | $9.22M | -68.8% | ||
| 2003 | $29.53M | +8.0% | ||
| 2002 | $27.34M | -46.7% | ||
| 2001 | $51.25M | -38.3% | ||
| 2000 | $83.08M | +1692.4% | ||
| 1999 | $4.64M | — |
Cash on Hand values are taken from Insmed's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Insmed (INSM) most recent annual cash and short-term investments stands at $1.43B (2025) – edged down 0.3% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Insmed cash and short-term investments compounded at +21.8% per year, with the latest reading among the more recent periods of the dataset.
2024 marks the peak cash and short-term investments at $1.43B, with the historical low of $2.40M recorded in 2008.
Among 8 Healthcare peers, Insmed (INSM) ranks 9th; the peer median for cash and short-term investments is $11.85B.
Insmed Cash on Hand by Year
Insmed Cash on Hand 2025: $1.43B
Insmed cash and short-term investments in 2025 was $1.43B, edged down 0.3% below 2024.
Insmed Cash on Hand 2024: $1.43B
Insmed cash and short-term investments in 2024 was $1.43B, surged 83.7% from 2023. This figure represents the highest annual value in the available history.
Insmed Cash on Hand 2023: $780.45M
Insmed cash and short-term investments in 2023 was $780.45M, plunged 32.0% below 2022.
Insmed Cash on Hand 2022: $1.15B
Insmed cash and short-term investments in 2022 was $1.15B, surged 60.2% from 2021.
Insmed Cash on Hand 2021: $716.78M
Insmed cash and short-term investments in 2021 was $716.78M.
See more financial history for Insmed (INSM).
Sector peers — Cash on Hand
Companies in the same sector as Insmed, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Insmed's cash and short-term investments?
- Latest reported cash and short-term investments for Insmed (INSM) is $1.43B (period ending December 31, 2025).
How has Insmed cash and short-term investments changed year-over-year?
- Insmed (INSM) cash and short-term investments changed -0.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Insmed cash and short-term investments?
- Insmed (INSM) cash and short-term investments compound annual growth rate is +21.8% over the most recent 5 years available.
When did Insmed cash and short-term investments hit its highest annual value?
- Insmed cash and short-term investments reached its highest annual value of $1.43B in 2024.
What was Insmed cash and short-term investments in 2024?
- Insmed (INSM) cash and short-term investments in 2024 was $1.43B.
What was Insmed cash and short-term investments in 2025?
- Insmed (INSM) cash and short-term investments in 2025 was $1.43B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INSM Overview
Company profile, financial tools, and key metrics
INSM Revenue Counter
Earns $19.23 every second. See per minute, hour, and day.
INSM Earnings Counter
Loses −$40.49 per second. See per minute, hour, and day.
INSM Economic Scale
Exceeds Micronesia, Fed. Sts.'s GDP. Compare with world economies.
INSM What If Invested
What if you had invested $1,000? See historical returns from any date.
INSM How It Makes Money
Discover visual breakdown of $606.42M in revenue — where it comes from and where it goes.
INSM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INSM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INSM Daily Price Character
Explosive · 46.7% historical win rate (green days). Streaks & record days.
INSM Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.
INSM Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.